PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Jul-2022 Athersys and Aspire Capital Fund Terminate Relationship Businesswire
08-Jul-2022 Global Proteomics Partnering Terms and Agreements 2010-2022: Trends, Deals and Key Players - ResearchAndMarkets.com Businesswire
08-Jul-2022 Global Hospital Care Partnering 2015-2022: Featuring Key Players Aesthetic Management Partners, AstraZeneca, Alliance Medical & Others - ResearchAndMarkets.com Businesswire
08-Jul-2022 Electric Heat Tracing Market Report 2022-2027: Increasing Adoption of Electric Heat Tracing Systems Over Conventional Steam Tracing Drivin - ResearchAndMarkets.com Businesswire
08-Jul-2022 Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference Businesswire
08-Jul-2022 invoX Pharma Commences Tender Offer for F-star Therapeutics, Inc. Businesswire
08-Jul-2022 Aerie Pharmaceuticals Announces New Employee Inducement Grant Businesswire
08-Jul-2022 Insights on the Beauty Drinks Global Market to 2027 - by Type, Ingredients, Function, Distribution Channel and Region - ResearchAndMarkets.com Businesswire
08-Jul-2022 Allergic Rhinitis Market and Epidemiology Report 2022 - ResearchAndMarkets.com Businesswire
08-Jul-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
08-Jul-2022 ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Europe and Select International Territories Businesswire
07-Jul-2022 Thermo Fisher Scientific Declares Quarterly Dividend Businesswire
07-Jul-2022 Kezar Life Sciences to Present at the William Blair Biotech Focus Conference Businesswire
07-Jul-2022 IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022 Businesswire
07-Jul-2022 Medpace Holdings, Inc. to Report Second Quarter 2022 Financial Results on July 25, 2022 Businesswire
07-Jul-2022 Life Sciences BC Announces 24th Annual Award Winners Businesswire
07-Jul-2022 Baron & Budd Investigates Potential Customs Fraud Cases Businesswire
07-Jul-2022 Insights on the Chloromethane Global Market to 2028 - Rising Demand as a Chemical Intermediate is Driving Growth - ResearchAndMarkets.com Businesswire
07-Jul-2022 Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality Businesswire
07-Jul-2022 The Worldwide Chronic Obstructive Pulmonary Disease Treatment Industry is Expected to Reach $104 Billion by 2027 - ResearchAndMarkets.com Businesswire